The stock of Telesis Bio Inc (TBIO) has seen a -24.12% decrease in the past week, with a -38.59% drop in the past month, and a 5.78% flourish in the past quarter. The volatility ratio for the week is 20.29%, and the volatility levels for the past 30 days are at 14.35% for TBIO. The simple moving average for the past 20 days is -23.49% for TBIO’s stock, with a -57.29% simple moving average for the past 200 days.
Is It Worth Investing in Telesis Bio Inc (NASDAQ: TBIO) Right Now?
Company’s 36-month beta value is 1.91.Analysts have differing opinions on the stock, with 1 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for TBIO is 8.78M, and currently, short sellers hold a 1.14% ratio of that floaft. The average trading volume of TBIO on April 19, 2024 was 760.90K shares.
TBIO) stock’s latest price update
Telesis Bio Inc (NASDAQ: TBIO) has experienced a decline in its stock price by -12.89 compared to its previous closing price of 0.38. However, the company has seen a fall of -24.12% in its stock price over the last five trading days. InvestorPlace reported 2024-02-23 that Telesis Bio (NASDAQ: TBIO ) stock is on the rise Friday as the synthetic biology company’s shares experienced heavy trading this morning. Shares of TBIO stock are off to a strong start on Friday with some 7.4 million shares changing hands as of this writing.
TBIO Trading at -26.83% from the 50-Day Moving Average
After a stumble in the market that brought TBIO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -89.00% of loss for the given period.
Volatility was left at 14.35%, however, over the last 30 days, the volatility rate increased by 20.29%, as shares sank -26.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +1.56% upper at present.
During the last 5 trading sessions, TBIO fell by -24.12%, which changed the moving average for the period of 200-days by -78.78% in comparison to the 20-day moving average, which settled at $0.4265. In addition, Telesis Bio Inc saw -17.04% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at TBIO starting from Nelson Todd Robert, who sale 2,575 shares at the price of $2.83 back on May 04 ’23. After this action, Nelson Todd Robert now owns 136,072 shares of Telesis Bio Inc, valued at $7,277 using the latest closing price.
Gibson Daniel Glenn, the Chief Technology Officer of Telesis Bio Inc, sale 1,190 shares at $2.83 during a trade that took place back on May 04 ’23, which means that Gibson Daniel Glenn is holding 102,083 shares at $3,363 based on the most recent closing price.
Stock Fundamentals for TBIO
Current profitability levels for the company are sitting at:
- -1.28 for the present operating margin
- 0.59 for the gross margin
The net margin for Telesis Bio Inc stands at -1.73. The total capital return value is set at -0.56. Equity return is now at value -125.42, with -62.89 for asset returns.
Based on Telesis Bio Inc (TBIO), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -4.89. The debt to equity ratio resting at 0.24. The interest coverage ratio of the stock is -11.32.
Currently, EBITDA for the company is -31.05 million with net debt to EBITDA at -0.98. When we switch over and look at the enterprise to sales, we see a ratio of 1.55. The receivables turnover for the company is 4.6for trailing twelve months and the total asset turnover is 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.71.
Conclusion
In a nutshell, Telesis Bio Inc (TBIO) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
